ClinicalTrials.Veeva

Menu

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

O

Oui Therapeutics

Status and phase

Enrolling
Phase 2

Conditions

Post Traumatic Stress Disorder
PTSD

Treatments

Device: OTX-601 Digital Therapeutic
Device: OTX-003 Comparator app

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT07316088
R44MH136888 (U.S. NIH Grant/Contract)
2024-Oui-002-Study2

Details and patient eligibility

About

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Full description

The purpose of this study is to conduct a randomized controlled trial to evaluate the efficacy of OTX-601 (intervention) compared to OTX-003 (comparator) in reducing PTSD symptoms from baseline to 7 weeks.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Posttraumatic stress disorder (PTSD) diagnosis
  • Anxiety Sensitivity Index 3 (ASI-3) scores above 24
  • PTSD Checklist for DSM-V (PCL-5) scores above 30
  • Understands and speaks English
  • Access to a smartphone that is connected to the internet

Exclusion criteria

  • Score of 24 or lower on the ASI-3
  • Score of 30 and below on the PCL-5
  • No PTSD diagnosis
  • Active psychosis
  • Acute intoxication during study baseline
  • Enrolled in another treatment research study
  • Medical illness that would prevent the completion of interoceptive exposure exercises

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

40 participants in 2 patient groups

OTX-601
Experimental group
Description:
A prescription digital therapeutic designed to overcome existing barriers and deliver evidence based treatment for PTSD
Treatment:
Device: OTX-601 Digital Therapeutic
OTX-003
Sham Comparator group
Description:
OTX-003 is a smartphone application developed as a comparator to OTX-601 and designed to match its interface while providing no active PTSD treatment.
Treatment:
Device: OTX-003 Comparator app

Trial contacts and locations

1

Loading...

Central trial contact

Brian Keenaghan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems